Recordati SpA (RER1.DU)
| Previous close | 48.68 |
| Open | 48.90 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 48.56 - 49.00 |
| 52-week range | 41.10 - 53.10 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Bloomberg
KKR, TPG Express Interest in Italian Drugmaker Recordati
(Bloomberg) -- KKR & Co., TPG Inc. and Advent International are among suitors that have expressed initial interest in Italian drugmaker Recordati SpA, people familiar with the matter said.Most Read from BloombergWhat to Know About the Deadly Flesh-Eating Bacteria Spreading in Japan‘I Live in Hell’: Anti-Growth Fervor Grips US South After Pandemic BoomNvidia Becomes World’s Most Valuable Company as AI Rally Steams AheadStocks Rise as Bullish Nvidia Call Boosts AI Trade: Markets WrapI Didn’t Think
- Reuters
UPDATE 1-CVC explores options for Italy's Recordati, Bloomberg News reports
CVC Capital Partners is exploring options for its controlling stake in Italian pharmaceutical group Recordati SpA, Bloomberg News reported on Tuesday, citing people familiar with the matter. CVC and Recordati did not immediately respond to a Reuters request for comments. A CVC-led consortium of investment funds had agreed to buy 51.8% of Recordati in a deal worth about 3 billion euros in 2018.
